Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan PK in Chinese patients with acute leukemia
NCT01498016Phase 2Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Nov 2011
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
busulfan
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01498016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01498016.